The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

The Lancet Oncology

Volumn 9, Issue 4, 2008, Pages 331-341

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RELAPSE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PHOTOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; STANDARDIZATION; TREATMENT RESPONSE; UNITED KINGDOM;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CONFIDENCE INTERVALS; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; KAPLAN-MEIERS ESTIMATE; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; REFERENCE VALUES; RISK ASSESSMENT; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 40949094327     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(08)70077-9     Document Type: Article

References (30)

1. Clarke M., Collins R., Darby S., et al., for the Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
2. Overgaard M., Bentzen S., Christensen J., and Madsen E. The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. Radiother Oncol 9 (1987) 1-11
3. Jones B., Dale R., Deehan C., Hopkins K., and Morgan D. The role of biologically effective dose (BED) in clinical oncology. Clin Oncol (R Coll Radiol) 13 (2001) 71-81
4. Bentzen S., Saunders M., and Dische S. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer. Radiother Oncol 53 (1999) 219-226
5. Stuschke M., and Thames H. Fractionation sensitivities and dose-control relations of head and neck carcinomas: analysis of the randomized hyperfractionation trials. Radiother Oncol 51 (1999) 113-121
6. Whelan T., MacKenzie R., Julian J., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94 (2002) 1143-1150
7. Yarnold J., Ashton A., Bliss J., et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 75 (2005) 9-17
8. Owen J., Ashton A., Bliss J., et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 7 (2006) 467-471
9. The START Trialists' Group. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet (2008) 10.1016/S0140-6736(08)60348-7 published online March 19.
10. Hopwood P., Haviland J., Mills J., Sumo G., and Bliss J. The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). Breast 16 (2007) 241-251
11. ICRU. Prescribing, recording and reporting photon beam therapy. Bethsada: Interantional Commission on Radiation Units and Measurements (ICRU), 1999: Report 62. Supplement to ICRU Report 50.
12. Venables K., Winfield E., Deighton A., Aird E., and Hoskin P. Breast radiotherapy phantom design for the START trial. START trial management group. Br J Radiol 73 (2000) 1313-1316
13. Venables K., Winfield E., Deighton A., Aird E., and Hoskin P. The START trial-measurements in semi-anatomical breast and chest wall phantoms. Phys Med Biol 46 (2001) 1937-1948
14. Venables K., Winfield E., Deighton A., Aird E., and Hoskin P. A survey of radiotherapy quality control practice in the United Kingdom for the START trial. Radiother Oncol 60 (2001) 311-318
15. Venables K., Winfield E., Aird E., and Hoskin P. Three-dimensional distribution of radiation within the breast: an intercomparison of departments participating in the START trial of breast radiotherapy fractionation. Int J Radiat Oncol Biol Phys 55 (2003) 271-279
16. Venables K., Miles E., Aird E., and Hoskin P. The use of in vivo thermoluminescent dosimeters in the quality assurance programme for the START breast fractionation trial. Radiother Oncol 71 (2004) 303-310
17. Venables K., Miles E., Hoskin P., and Aird E. Verification films: a study of the daily and weekly reproducibility of breast patient set-up in the START trial. Clin Oncol (R Coll Radiol) 17 (2005) 337-342
18. Venables K., Miles E., Aird E., and Hoskin P. What is the optimum breast plan: a study based on the START trial plans. Br J Radiol 79 (2006) 734-739
19. Aaronson N., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
20. Sprangers M., Groenvold M., Arraras J., et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14 (1996) 2756-2768
21. Hopwood P., Fletcher I., Lee A., and Al Ghazal S. A body image scale for use with cancer patients. Eur J Cancer 37 (2001) 189-197
22. Zigmond A., and Snaith R. The hospital anxiety and depression scale. Acta Psychiatr Scand 67 (1983) 361-370
23. Altman D., and Andersen P. Calculating the number needed to treat for trials where the outcome is time to an event. BMJ 319 (1999) 1492-1495
24. Cohen L. Radiotherapy in breast cancer I. The dose-time relationship theoretical considerations. Br J Radiol 25 (1952) 636-642
25. Douglas B., and Castro J. Novel fractionation schemes and high linear energy transfer. Prog Exp Tumor Res 28 (1984) 152-165
26. Bentzen S., and Ritter M. The alpha/beta ratio for prostate cancer: What is it, really?. Radiother Oncol 76 (2005) 1-3
27. Thames H., Bentzen S., Turesson I., Overgaard M., and Van den Bogaert W. Time-dose factors in radiotherapy: a review of the human data. Radiother Oncol 19 (1990) 219-235
28. Hurkmans C., Cho B., Damen E., Zijp L., and Mijnheer B. Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Oncol 62 (2002) 163-171
29. Bentzen S. Steepness of the radiation dose-response curve for dose-per-fraction escalation keeping the number of fractions fixed. Acta Oncol 44 (2005) 825-828
30. Bentzen S. High-tech in radiation oncology: should there be a ceiling?. Int J Radiat Oncol Biol Phys 58 (2004) 320-330